8-K//Current report
Clarus Therapeutics Holdings, Inc. 8-K
Accession 0001213900-22-067678
CIK 0001817944operating
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:15 PM ET
Size
732.9 KB
Accession
0001213900-22-067678
Documents
- 8-Kea167801-8k_clarusthera.htmPrimary
CURRENT REPORT
- EX-2.1ea167801ex2-1_clarusthera.htm
ASSET PURCHASE AGREEMENT, DATED AS OF OCTOBER 25, 2022, BY AND BETWEEN CLARUS THERAPEUTICS HOLDINGS, INC., CLARUS THERAPEUTICS, INC., TOLMAR, INC. AND TOLMAR HOLDINGS, INC.
- EX-101.SCHcrxtq-20221025.xsd
XBRL SCHEMA FILE
- EX-101.LABcrxtq-20221025_lab.xml
XBRL LABEL FILE
- EX-101.PREcrxtq-20221025_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLea167801-8k_clarusthera_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-22-067678-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001817944
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:15 PM ET
- Size
- 732.9 KB